Vyepti®

Understanding Vyepti®

Vyepti® is used for the preventive treatment of migraine in adults. It works by blocking calcitonin gene-related peptide (CGRP), a key molecule involved in migraine attacks. By inhibiting CGRP—a protein that contributes to migraines through inflammation and blood vessel dilation in the brain—Vyepti® helps prevent migraines before they start, reducing their frequency, severity, and duration.

How Vyepti® Works:

• Targets and blocks CGRP, preventing migraine-related inflammation and pain.
• Reduces migraine frequency, severity, and duration for long-term relief.
• Provides an IV treatment option for patients seeking a long-acting preventive therapy.

FDA Approval:

• Vyepti®: Approved on February 21, 2020, for migraine prevention.

For more information, please visit the Vyepti® patient website and speak with your healthcare provider to determine if Vyepti® is the right treatment option for you.